Sunshine Biopharma Inc. (SBFM): EBITDA
-$5.89M
Year ended 2025-12-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.89M | n/m | 2026-04-03, From 2025-01-01 |
| 2024-12-31 | -$5.59M | n/m | 2026-04-03, From 2024-01-01 |
| 2023-12-31 | -$4.64M | n/m | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | -$26.98M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$2.43M | n/m | 2023-04-04, From 2021-01-01 |
| 2020-12-31 | -$562.8K | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$627.9K | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$1.11M | n/m | 2020-05-01, From 2018-01-01 |
| 2017-12-31 | -$850.6K | n/m | 2019-04-12, From 2017-01-01 |
| 2016-12-31 | -$932.4K | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$776.0K | n/m | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | -$1.76M | n/a | 2016-03-25, From 2014-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.89M | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $1.47M | n/m |
| BGM Group Ltd. (BGM) | 2025-09-30 | -$11.12M | n/m |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | -$3.95M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$11.21M | n/m |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | -$83.06M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$40.44M | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $1.35M | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$70.50M | n/m |
Compare SBFM, LIFD, BGM, BHST side by side · Screen every company in Pharmaceutical Preparations ↗